October 21, 2020

Faraday Future Completes Bridge Financing to Push Forward Production of Its All-electric FF 91 Luxury Vehicle

  • Amended Bridge Financing Includes up to $45 Million in New Senior Secured Financing

  • Birch Lake Fund Management LP, Which Led Senior Bridge Financing Facility in 2019, Returns to Support Faraday Future

 

Faraday Future (FF), a California-based global shared intelligent mobility ecosystem company, today announced that it has completed the expansion and extension of the senior bridge financing facility put in place in 2019 to support the completion and launch of its flagship FF 91 EV and continue development of the mass-market FF 81. The amended bridge facility includes new senior secured financing of up to $45 million, which matures in October 2021.

As part of the expanded and extended financing agreement, Birch Lake, a Chicago-based merchant bank, has returned to support FF as the majority purchaser of the new senior secured financing. The principals of Birch Lake and co-investor, ATW Partners, a New York-based private equity firm, bring extensive experience

Read More

Transportation and Logistics Systems, Inc. Closes $640,000 Financing

Company Continues to Pursue Growth Opportunities

JUPITER, FL / ACCESSWIRE / October 13, 2020 / Transportation and Logistics Systems, Inc. (OTC PINK:TLSS), (“TLSS”, or the “Company”), a leading eCommerce fulfillment service provider, today announced that on October 8, 2020 it closed an equity financing which provided gross proceeds of $640,000.

According to CEO John Mercadante, “In light of the significant positive results from our restructuring efforts over the past six months and then the cessation of our Amazon DSP business as of September 30, 2020, we believe that this interim funding will enable us to continue to pursue opportunities to build shareholder value. We appreciate the ongoing support demonstrated by the investors in this financing.”

Under the terms of a Securities Purchase Agreement, the Company issued to certain accredited investors in a private placement an aggregate of 47,977 shares of Series E Convertible Preferred Stock of the Company, par value

Read More

Bicycle Therapeutics Announces Gross Proceeds of $50.0 Million from its At-the-Market Offering Program and Enters into Debt Financing from Hercules Capital

CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (Nasdaq: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that it has completed its at-the-market (ATM) offering program initiated during the third quarter, generating gross proceeds of $50.0 million. Cantor Fitzgerald & Co. and Oppenheimer & Co. Inc. acted as placement agents for the offering.

In addition, Bicycle announced that it has closed a financing with Hercules Capital, Inc. (NYSE: HTGC) for a term loan of up to $40.0 million in two tranches. Under the terms of the loan and security agreement, an initial tranche of $30.0 million will be fully available at the loan closing, with a minimum draw of $15.0 million.

“I am pleased to announce the successful utilization of our ATM program and our flexible financing with Hercules, which have further

Read More